Opportunity for the LASERBLOOD project

What does it take to detect pancreatic cancer at its very earliest stages?

At The IFO-ReginaElena-SanGallicano, one of our partners, researchers are pushing the boundaries of pre-clinical science to uncover the subtle biological changes that signal the disease long before symptoms appear.

Their work is helping pave the way for earlier, more effective diagnostics—and ultimately, better outcomes for patients.

In our latest consortium meeting, we spoke with Giulia Piaggio and Giulia Cristinziano about their contribution to this ambitious mission and the science driving it forward.

More voices from across the project coming soon—stay tuned!

https://www.instagram.com/reel...

https://www.youtube.com/shorts...

Sign up to the Crowdhelix Pancreatic Cancer for more LASERBLOOD project updates!


Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them. This project has received funding from the European Union’s EIC Pathfinder under grant agreement No 101130740.

Funded by
the European Union